Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current and emerging EGFR therapies for glioblastoma.
Artene SA, Tuţă C, Dragoi A, Alexandru O, Stefana Oana P, Tache DE, Dănciulescu MM, Boldeanu MV, Siloşi CA, Dricu A. Artene SA, et al. Among authors: alexandru o. J Immunoassay Immunochem. 2018;39(1):1-11. doi: 10.1080/15321819.2017.1411816. Epub 2018 Feb 2. J Immunoassay Immunochem. 2018. PMID: 29308973 Review.
Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
Carapancea M, Cosaceanu D, Budiu R, Kwiecinska A, Tataranu L, Ciubotaru V, Alexandru O, Banita M, Pisoschi C, Bäcklund ML, Lewensohn R, Dricu A. Carapancea M, et al. Among authors: alexandru o. J Neurooncol. 2007 Dec;85(3):245-54. doi: 10.1007/s11060-007-9417-0. Epub 2007 Jun 14. J Neurooncol. 2007. PMID: 17568996
Growth factor receptors signaling in glioblastoma cells: therapeutic implications.
Carapancea M, Alexandru O, Fetea AS, Dragutescu L, Castro J, Georgescu A, Popa-Wagner A, Bäcklund ML, Lewensohn R, Dricu A. Carapancea M, et al. Among authors: alexandru o. J Neurooncol. 2009 Apr;92(2):137-47. doi: 10.1007/s11060-008-9753-8. Epub 2008 Nov 30. J Neurooncol. 2009. PMID: 19043776
Plasma levels of glucose and insulin in patients with brain tumors.
Alexandru O, Ene L, Purcaru OS, Tache DE, Popescu A, Neamtu OM, Tataranu LG, Georgescu AM, Tudorica V, Zaharia C, Dricu A. Alexandru O, et al. Curr Health Sci J. 2014 Jan;40(1):27-36. doi: 10.12865/CHSJ.40.01.05. Epub 2013 Dec 29. Curr Health Sci J. 2014. PMID: 24791202 Free PMC article.
Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.
Popescu AM, Alexandru O, Brindusa C, Purcaru SO, Tache DE, Tataranu LG, Taisescu C, Dricu A. Popescu AM, et al. Among authors: alexandru o. Int J Clin Exp Pathol. 2015 Jul 1;8(7):7825-37. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339347 Free PMC article.
New perspectives in glioblastoma antiangiogenic therapy.
Popescu AM, Purcaru SO, Alexandru O, Dricu A. Popescu AM, et al. Among authors: alexandru o. Contemp Oncol (Pozn). 2016;20(2):109-18. doi: 10.5114/wo.2015.56122. Epub 2015 Dec 8. Contemp Oncol (Pozn). 2016. PMID: 27358588 Free PMC article. Review.
Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
Serban F, Daianu O, Tataranu LG, Artene SA, Emami G, Georgescu AM, Alexandru O, Purcaru SO, Tache DE, Danciulescu MM, Sfredel V, Dricu A. Serban F, et al. Among authors: alexandru o. J Immunoassay Immunochem. 2017;38(1):21-33. doi: 10.1080/15321819.2016.1209217. Epub 2016 Jul 5. J Immunoassay Immunochem. 2017. PMID: 27379831
26 results